Expression of the p53 gene plays an important role in the regulation of cellular proliferation and malignant transformation. Overexpression of mutant forms of p53 is in fact a common feature of many transformed cells. Studies dealing with the transcriptional regulatory regions of the p53 gene indicate that, unlike most promoters transcribed by RNA polymerase II, the p53 promoter contains no TATA-like sequence upstream of the transcription start site. Here we demonstrate that the murine p53 promoter contains a cis-acting element that maps downstream to the transcription initiation site. The integrity of this element is required for high-level expression from the promoter in transformed cells. By DNase I protection and mobility-shift analysis, we show that a nuclear factor binds to this downstream element through the consensus recognition sequence for the helix-loop-helix (HLH)-containing proteins of the myc/MyoD family of transcriptional regulators. We propose that the activity of one or more members of this family of transcription factors is an important determinant in the expression of p53 and that at least one level of p53 overexpression in transformed cells may thus be due to aberrant expression of the relevant factor(s). Furthermore, the possibility that the regulation of expression of p53 occurs, in part, by means of a potential HLH-containing factor provides a possible mechanism for the suppression ofproliferation by the MyoD family of transcriptional regulators.
possibility that the regulation of expression of p53 occurs, in part, by means of a potential HLH-containing factor provides a possible mechanism for the suppression ofproliferation by the MyoD family of transcriptional regulators.
Recent evidence has indicated that p53 is a growth modulator and that aberrant expression or inactivation of p53 is a frequent event in the genesis of many malignancies. The role of p53 in growth regulation is supported by the observations that overexpression of wild-type p53 inhibits cellular proliferation (1) (2) (3) (4) , that expression of the gene is induced prior to S phase (5) , and that p53 is phosphorylated by the cell cycle regulator p34cdc2 (6, 7) . In addition, the wild-type p53 gene has been shown to inhibit transformation in vitro (4, 8) and a frequent property of many malignantly transformed cells is either the loss of wild-type p53 expression (9) (10) (11) (12) (13) or overexpression of mutant forms of p53 (14, 15) . Furthermore, in cooperation with the ras oncogene, overexpression ofmutant p53 leads to the transformation of normal embryonic cells (16) (17) (18) . Mutant forms of p53 have been proposed to function in transformation by a dominant negative mechanism (19) , possibly by interacting with endogenous wild-type p53 (8) or its cellular targets.
Although the molecular basis of p53 involvement in cell proliferation and malignant transformation has not yet been defined, a role in the regulation of DNA replication and mRNA transcription is suggested by recent findings. p53 was shown to compete with DNA polymerase a for binding to the simian virus 40 (SV40) large tumor antigen and to inhibit the initiation of SV40 replication in vitro (20) (21) (22) . In addition, it was recently demonstrated that wild-type p53, but not mutant p53, can function as a transcriptional activator when present in cells as a fusion with the DNA-binding domain of the yeast transcription factor GAL4 (23, 24) . Both of these functions are consistent with the active nuclear localization of p53 (25) (26) (27) .
To define elements involved in regulating transcription of the p53 gene, we and others have been analyzing regulatory regions of the gene (28) (29) (30) (31) (32) . Unlike many genes transcribed by RNA polymerase II, the p53 promoter lacks a TATA box (28, 33) . Other promoters that lack the TATA box have recently been shown to contain sequences downstream ofthe transcription start site that bind factors that influence the activity of the promoter (34) (35) (36) (37) . By analogy, we predicted that the p53 promoter may contain similar regulatory domains. Here we report the identification of an essential downstream element that binds to a cellular factor through a consensus recognition sequence for the helix-loop-helix (HLH)-containing myc/MyoD family of transcriptional activators (38) (39) (40) . Binding to this downstream element correlates with elevated expression from the p53 promoter and thus may be necessary for maximal trans-activation of the promoter in transformed cells. The finding that positive regulation of expression of p53 may occur by means of a HLH-containing factor provides one possible mechanism for the suppression of proliferation by the MyoD family of transcriptional regulators.
MATERIALS AND METHODS
Recombinant Plasmids. A series of 3' deletions were generated within a 0.7-kilobase-pair (kbp) EcoRI-HindIII fragment (see Fig. 1 ) containing the 5' end of the murine p53 gene (28) . This DNA fragment contains a functional promoter as well as sequences that extend 348 bp downstream of the initiation site comprising the 216-bp noncoding first exon and 132 bp from the first intron. Deletions were generated either by digestion of the DNA with appropriate restriction enzymes (e.g., Hae III for p0.49CAT and Ava II for pAACAT) or by digestion with BAL-31. The deletion endpoints were approximated (within 5 bp) by electrophoresis of the fragments through 2% agarose relative to appropriate markers. This intact fragment and the deletion derivatives were cloned directly upstream to the Escherichia coli chloramphenicol acetyltransferase (CAT) gene on the vector pUC18CAT.
Cell Culture, DNA Transfections, and CAT Assays. The murine cell lines BALB/c-3T3, NIH 3T3, SVT2, and MethA were cultured in Dulbecco's modified Eagle's minimal essential medium containing 10o fetal bovine serum. Fifteen micrograms of each plasmid was introduced into =1 x 106 cells from each cell line by calcium phosphate coprecipitation (41) . After 5 hr in the presence of the precipitate, the cells were treated with 20% glycerol in complete medium for 2 min. The cells were washed and maintained in complete medium. After 48 hr, extracts were prepared and assayed for CAT activity (42) Preparation of DNA Probes and DNA-Protein-Binding Assays. An 80-bp Alu I restriction fragment extending from nucleotides + 18 to +98 was subcloned into the EcoRV site of the polylinker of pBluescript (Stratagene). The orientation of the insert was determined by the nucleotide sequence of the junctions. The insert was released from the vector by digestion at the polylinker with Xba I plus Sal I and purified by electrophoresis through 5% polyacrylamide. The ends of the fragment were radiolabeled by reaction with [a-32P]dATP (>3000 Ci/mmol; 1 Ci = 37 GBq) and E. coli DNA polymerase I (Klenow fragment). To generate singly end-labeled fragments, the 32P-labeled DNA was digested with either HindIII or BamHI to remove the radioactivity from the noncoding or coding strand, respectively. Nuclear extracts were prepared from SVT2 cells as described (43) . For DNase I protection analysis, binding reaction mixtures contained nuclear extract, 20 fmol of end-labeled DNA, 1 ,ug ofpoly(dIdC), 25 mM Tris-HCl (pH 7.9), 50 mM KCl, 6 .25 mM MgCl2, 0.5 mM EDTA, 1 mM dithiothreitol, and 10%o glycerol in a volume of 50 ,ul. Samples were treated with DNase I, purified, and separated by electrophoresis through 7.0% acrylamide/8 M urea gels as described (44) . For electrophoretic mobility-shift assays, binding reaction mixtures contained 10 ,ug of nuclear extract, 20 fmol of end-labeled DNA, 2 ,g of poly(dI-dC), 2 ,ug of calf thymus DNA, 80 mM NaCl, 10 mM Tris*HCl (pH 7.5), 1 mM EDTA, 0.1% Triton X-100, 10 mM 2-mercaptoethanol, and 4% glycerol in a volume of 25 Al. The mixture was incubated on ice for 15 min followed by incubation at 20°C for 15 min and electrophoresed through 4% polyacrylamide gels in the presence of 0.045 M Trisborate/1 mM EDTA (0.Sx TBE). For competition experiments, oligonucleotides were added to the binding reaction mixtures prior to addition of nuclear extract. An oligonucleotide containing an NF-1-binding site contains the sequence 5'-GATCCCCCGGCTCAGGGCCAAGAAC-3' and was taken from position 8056 to 8076 from the long terminal repeat (LTR) of Moloney murine leukemia virus (Mo-MuLV) (45, 46) . RNA Analysis. Total RNA was isolated by extraction with guanidium isothiocynate and purified by centrifugation through 5.7 M CsCl (47); 50 Mg ofRNA from each cell line was resuspended in 50%o formamide/6% formaldehyde/lx SSC (SSC = 0.15 M NaCl/15 mM sodium citrate) and heated at 60°C for 10 min. Two-fold serial dilutions were prepared and applied to duplicate nitrocellulose filters. The filters were baked at 80°C for 2 hr and hybridized to 32P-labeled CAT coding sequences or to 32P-labeled actin-specific sequences.
RESULTS

Identification of a Downstream Promoter Element Within
the Murine p53 Gene. To determine whether sequences downstream of the transcription initiation site influence the activity of the p53 promoter, we generated a series of 3' deletions within an =0.7-kbp EcoRI-HindIll fragment containing the 5' end of the murine p53 gene (27) . This DNA fragment contains a functional promoter as well as sequences that extend 348 bp downstream of the initiation site comprising the 216-bp noncoding first exon and 132 bp from the first intron ( Fig. 1 ). This intact fragment and the 3' deletion derivatives, generated by digestion with BAL-31 exonuclease, were cloned directly upstream to the E. coli CAT gene and tested for their ability to transiently direct expression of the reporter gene in the SV40-transformed murine cell line SVT2. These cells were chosen because they express high levels of endogenous p53 (data not shown) and are therefore well suited for characterizing the molecular basis of p53 overexpression. As shown in Fig. 1 Genetics: Ronen et al. (Fig. 2a ). An examination of the nucleotide sequence of the protected region revealed the presence of the sequence CACGTG (nucleotides +70 to +75). This nucleotide sequence is a match to the consensus recognition site (CANNTG) for the myc/MyoD family of HLH-containing transcriptional activators (39, 48) . To test whether this specific site is required for protein binding we performed electrophoretic mobility-shift assays on the 80-bp Alu I fragment with nuclear extracts prepared from SVT2 cells. Doublestranded oligonucleotides containing either the putative wildtype HLH recognition sequence (CACGTG) or mutations in this sequence (GGTGTG) were used as competitors in the binding reactions. As shown in Fig. 2b , the wild-type sequence, which contains the HLH-binding motif, competed for binding to the 80-bp Alu I fragment, whereas mutations introduced into this sequence abolished the competition for binding (Fig. 2b) . These results, as well as the requirement of this downstream element for activity of the promoter, indicate that protein binding to the HLH recognition motif is likely to be required for high levels of expression of the p53 promoter. Proc. Natl. Acad. Sci. USA 88 (1991) Binding to the Downstream HLH Recognition Motif Correlates with Expression of the p53 Promoter in Transformed Cells. Since the mutant p53 gene is overexpressed in many transformed, but not immortalized, cells, we sought to determine whether binding to the downstream promoter element correlates with high-level expression from the p53 promoter. We first assayed the expression of the CAT gene under control of the intact p53 promoter (pO.7CAT) in two transformed murine cell lines, SVT2 and MethA, and in two immortalized cell lines, NIH 3T3 and BALB/c-3T3. Measurement ofthe resulting CAT activities revealed that expression from the intact p53 promoter in SVT2 and MethA was 10-fold higher than in NIH 3T3 or BALB/c-3T3 (Fig. 3A) , consistent with the overexpression of the gene in these cells. As controls, the SV40 early promoter and the Moloney murine sarcoma virus (Mo-MuSV) LTR were also tested in this assay. These control promoters expressed the CAT gene at similar levels in all four cell types, indicating that the transfection efficiencies were similar and that the elevated expression of the p53 promoter in the transformed cells was specific. To confirm that the elevated CAT activity was due to increased levels of CAT mRNA, we measured the steady- Fig. 1 Fig. 2 ) was used. The oligonucleotide containing the NF-1-binding site contains the sequence 5'-GATCCCCCGGCTCAGGGC-CAAGAAC-3'. The DNA sequence of the NF-1 site was taken from positions 8056-8076 from the LTR of Mo-MuLV (45, 46) . state level of CAT-specific RNA transcribed from the p53 promoter by hybridization analysis. Two-fold serial dilutions of total cellular RNA were applied to nitrocellulose filters and hybridized to CAT-and actin-specific probes. Although the level of actin RNA was similar in BALB/c, MethA, and SVT2, the level of CAT RNA transcribed from the p53 promoter was 8-to 10-fold higher in MethA and SVT2 than in BALB/c (Fig. 3B ). These data demonstrate that the p53 promoter is trans-activated in MethA and SVT2 cells.
To determine whether the trans-activation of the p53 promoter in MethA and SVT2 cells correlates with the presence of the downstream binding activity, we performed electrophoretic mobility-shift assays using nuclear extracts obtained from the cell lines described above. The DNA fragment used to detect binding was the 80-bp Alu I fragment described in the legend to Fig. 2 that extends from + 18 to +98, spanning the protected HLH-binding motif. A specific protein-DNA complex was observed only when using extracts from SVT2 or MethA cells (Fig. 4) . Formation of the complex was inhibited by a 50-fold molar excess of the homologous DNA (fragment A) but not by a 100-fold molar excess of a nonspecific competitor (fragment B). No such protein-DNA complex was observed using extracts from either NIH 3T3 or BALB/c-3T3. These same NIH 3T3 and BALB/c-3T3 extracts, however, formed complexes with a control doublestranded oligonucleotide containing an NF-1-binding site (Fig.  4) . This finding indicates that the lack of complex formation with the p53 sequences using extracts derived from NIH 3T3 or BALB/c-3T3 was due to the absence of this downstream binding activity rather than a general lack of DNA-binding activity. These results demonstrate that factor binding to the downstream HLH motif within the p53 gene does correlate with expression from the p53 promoter and thus may be required for maximal trans-activation of the promoter in transformed cells.
DISCUSSION
Previous analysis of the murine p53 promoter has demonstrated that it lacks an upstream TATA box (28) . Recent findings with other promoters that lack a TATA box, such as the terminal deoxynucleotidyltransferase (49), dihydrofolate reductase (DHFR) (35, 50) , SV40 major late (34, 36) , and adenovirus IVa2 (37) indicate that features of this class of promoters include upstream (G+C)-rich Spl-binding sites (51) , protein binding at the transcription initiation site, and downstream regulatory elements. Binding at the initiation site appears to be required for correct positioning of transcription initiation (50) , whereas the downstream elements positively modulate the level of transcription (34) (35) (36) (37) . The murine p53 promoter contains structures analogous to those found in these other non-TATA box promoters. Sequence analysis indicates the presence of one short (G+C)-rich region between positions -41 and -51 containing a consensus Spl-binding site. In addition, Ginsberg et al. (32) identified an AP-1-like binding site between positions -52 and -68 as well as an NF-1-like binding site that overlaps the transcription initiation site (nucleotides -1 to +24). It remains to be determined whether, as in the case of the DHFR promoter, binding at the initiation site of the p53 promoter is required for correct positioning of transcription initiation. Here we have shown that the p53 promoter shares an additional feature of this class of promoters, a downstream regulatory element.
The p53 downstream element maps within the noncoding first exon of the gene between nucleotides +66 and +112. DNase I protection analysis of this region indicates that a protein binds within this sequence, protecting nucleotides +65 to +79. Interestingly, the protected region contains a consensus HLH protein-binding motif (CANNTG, 48 ), which we demonstrate is required for binding to this element. We conclude from our findings that binding to this downstream regulatory element is most likely necessary for high-level expression of the p53 promoter. This conclusion is based on the demonstration that deletion of this element reduces promoter activity -5-fold in SVT2 cells as well as on the demonstration that factor binding to this element is not detected in cells that do not efficiently express the promoter.
A comparison of the murine and human p53 nucleic acid sequences revealed the presence of a similar HLH recognition motif in the promoter of the human gene (CATGTG). Interestingly, as shown below, the sequences surrounding this element are also highly conserved (82%) (H, human; M, murine; C, consensus).
Although the putative HLH recognition site maps downstream to the transcription initiation site in the murine gene (+70 to +75), it maps upstream of the transcription initiation site in the human gene (-29 to -34). The fact that the sequences surrounding this site are so highly conserved indicates that they probably represent the same functional element in both genes. This suggests that the position of the element relative to the transcription start site may be less important. than the presence of the element within the promoter. In this regard, sequences downstream of the transcription start site, within the noncoding first exon of the murine gene, thus constitute part of the functional promoter. Since in the murine gene this element is transcribed into mRNA, we cannot exclude the formal possibility that transactivation may additionally involve protein-mRNA interactions as in case of the human immunodeficiency virus transactivator Tat (52 (38, 56) and functions in DNA binding and dimerization among different members of the family (38) . The 
